Dan Weng

EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.

Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials.

EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.